Skip to Content

Flucytosine Pregnancy and Breastfeeding Warnings

Flucytosine is also known as: Ancobon

Medically reviewed by Last updated on Jan 31, 2019.

Flucytosine Pregnancy Warnings

Flucytosine has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of species specific teratogenicity. There are no controlled data in human pregnancy. Flucytosine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Flucytosine Breastfeeding Warnings

There are no data on the excretion of flucytosine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Ancobon (flucytosine)." Roche Laboratories, Nutley, NJ.
  2. Thompson GR 3rd, Cadena J, Patterson TF "Overview of antifungal agents." Clin Chest Med 30 (2009): 203-15, v

References for breastfeeding information

  1. "Product Information. Ancobon (flucytosine)." Roche Laboratories, Nutley, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.